Clinical and genomic registry of myelodysplastic syndrome (MIDS) and secondary acute myeloid leukaemia (AML) in Asia
Grant Data
Project Title
Clinical and genomic registry of myelodysplastic syndrome (MIDS) and secondary acute myeloid leukaemia (AML) in Asia
Principal Investigator
Professor Singh, Gill Harinder Harry
(Principal Investigator (PI))
Co-Investigator(s)
Professor Kwong Yok Lam
(Co-Investigator)
Duration
48
Start Date
2019-01-01
Completion Date
2022-12-31
Amount
2808000
Conference Title
Clinical and genomic registry of myelodysplastic syndrome (MIDS) and secondary acute myeloid leukaemia (AML) in Asia
Keywords
and secondary acute myeloid leukaemia (AML) in Asia, Clinical and genomic registry, myelodysplastic syndrome (MIDS)
Discipline
Others - Medicine, Dentistry and Health
HKU Project Code
AR180044
Grant Type
Celgene International II SARL
Funding Year
2018
Status
Completed
Objectives
Refer to the hard copy of the project Agreement was reviewed by CTC (CTC1589). The project start/end date provided by the PI (by email). The project start date was 1 January 2017 and the project will end on 31 December 2021. The first 2 years were self-funded. The subsequent 3 years will be covered by Celgene.